Jesudasan K, Vijayakumaran P, Manimozhi N, Jeyarajan T, Rao P S
Schieffelin Leprosy Research and Training Centre, Karigiri, India.
Int J Lepr Other Mycobact Dis. 1996 Jun;64(2):133-5.
Thirty-four multibacillary patients with a bacterial index (BI) of 3+ or more were treated with 2 years of WHO multidrug therapy (WHO/MDT). Treatment was then stopped and the patients followed for a minimum of 4 years. The rate of fall in the BI in this group without further treatment was similar to the rate of fall in the BI in an earlier group of similar patients treated with MDT until skin-smear negativity. No relapses have been seen.
34例细菌指数(BI)为3+或更高的多菌型患者接受了为期2年的世界卫生组织多药疗法(WHO/MDT)治疗。然后停止治疗,并对患者进行至少4年的随访。该组在未进一步治疗情况下细菌指数的下降速率,与早期一组接受MDT治疗直至皮肤涂片转阴的类似患者的细菌指数下降速率相似。未观察到复发情况。